Our active researchers maintain the scientific integrity of every manuscript through objective, double-blind evaluation.
Scientific board directory
Our editors are active investigators spanning key life science disciplines, ensuring expert evaluation of your methodology.
Dr. Sukanta Nath
PhD in Biotechnology, Research Scientist, Department of Molecular Oncology, Atal Bihari Vajpayee Regional Cancer Centre, Tripura, India. Email ID: biologicscientificwriting@gmail.com
Prof. Ashok Sharma
PhD in Biochemistry, Professor, Department of Biochemistry, AIIMS, New Delhi, India. Email ID: ashok.sharma@aiims.edu
Dr. Prasanta Maiti
PhD in Life Sciences, Post Doctorate (Cellular and Molecular Immunology, Autoimmune Diseases), USA, Principal Scientist and Head, R&D, Imgenex India Pvt Ltd, Bhubaneswar, Odisha, India. Email ID: pmaiti@imgenexindia.com
Chief Editor, Molecular Biology. Senior researcher specializing in cellular signaling pathways and genomic translation.
Associate Editor, Biochemistry. Focuses on enzymatic kinetics, structural biology, and protein-ligand interactions.
Associate Editor, Immunology. Investigates cellular immune responses, immunotherapy vectors, and lymphatic oncology.
Dr. Md Rofiqul Islam
PhD in Biotechnology, Post Doctorate (IIT Guwahati), Assistant Director, Institute of Advanced Research and Development, University of Science and Technology (USTM), Meghalaya, India. Email ID: rofiqulislam@ustm.ac.in
Dr. Jyotsna Devi Godavarthi
PhD in Pharmaceutical Sciences, Postdoctoral Research Fellow (Behavioural and Biomedical Sciences), University of Texas Health Science Centre at Houston, Texas, USA. Email ID: jyotsna.d.godavarthi@uth.tmc.edu
Dr. Manash Barman
PhD in Bio-Statistics, Professor and Head, Department of Statistics, Dibrugarh University, Assam, India. Email ID: manash_stats@dibru.ac.in
Section Editor, Genetics. Researching epigenetic modifications, CRISPR-Cas9 therapeutics, and hereditary disease markers.
Section Editor, Pharmacology. Expert in pharmacokinetics, targeted drug delivery systems, and clinical trial validation.
Technical Editor, Biostatistics. Specializes in clinical trial design, multivariate analysis, and experimental data verification.
Double-blind evaluation process
We enforce a rigorous double-blind peer-review framework. Author identities and institutional affiliations remain completely concealed from reviewers, ensuring objective, unbiased scientific assessment.
Methodological scrutiny
Anonymized assessment
Zero tolerance policy
Every manuscript undergoes deep methodological validation. We verify statistical power, experimental controls, and data transparency.
Both authors and reviewers remain anonymous throughout. This eliminates institutional bias and focuses evaluation purely on discovery.
We maintain absolute vigilance against plagiarism, redundant publication, and compromised data. Integrity remains our single standard.